199. Oral antihypertensive treatment of severe hypertension in pregnancy – A randomized trial of 3 regimens

2018 ◽  
Vol 13 ◽  
pp. S30-S31 ◽  
Author(s):  
Thomas Easterling ◽  
Shuchita Mundle ◽  
Hillary Bracken ◽  
Laura Magee ◽  
Peter von Dadelszen ◽  
...  
Keyword(s):  
Randomized Trial ◽  
Antihypertensive Treatment ◽  
Severe Hypertension ◽  
Hypertension In Pregnancy ◽  
In Pregnancy

First-line antihypertensive treatment for severe hypertension in pregnancy: A systematic review and network meta-analysis

2019 ◽  
Vol 18 ◽  
pp. 179-187 ◽  
Author(s):  
Sepand Alavifard ◽  
Rebecca Chase ◽  
Ghayath Janoudi ◽  
Andréanne Chaumont ◽  
Andrea Lanes ◽  
...  
Keyword(s):  
Systematic Review ◽  
Antihypertensive Treatment ◽  
Severe Hypertension ◽  
Meta Analysis ◽  
First Line ◽  
Hypertension In Pregnancy ◽  
In Pregnancy

scholarly journals Tailored physiologic treatment of severe hypertension in pregnancy: a novel approach to hypertension management

2022 ◽  
Vol 226 (1) ◽  
pp. S282
Author(s):  
Allison M. Davis ◽  
Christina T. Blanchard ◽  
Akila Subramaniam ◽  
Rachel G. Sinkey ◽  
Alan T. Tita ◽  
...  
Keyword(s):  
Severe Hypertension ◽  
Hypertension Management ◽  
Hypertension In Pregnancy ◽  
Novel Approach ◽  
In Pregnancy

scholarly journals Hypertension in pregnancy: Pathophysiology and treatment

2019 ◽  
Vol 7 ◽  
pp. 205031211984370 ◽  
Author(s):  
Stephanie Braunthal ◽  
Andrei Brateanu
Keyword(s):  
Gestational Hypertension ◽  
Severe Hypertension ◽  
Organ Damage ◽  
Morbidity And Mortality ◽  
Perinatal Morbidity ◽  
Hypertensive Disorders Of Pregnancy ◽  
Hypertension In Pregnancy ◽  
Hypertensive Disorders ◽  
In Pregnancy ◽  
The Ideal

Hypertensive disorders of pregnancy, an umbrella term that includes preexisting and gestational hypertension, preeclampsia, and eclampsia, complicate up to 10% of pregnancies and represent a significant cause of maternal and perinatal morbidity and mortality. Despite the differences in guidelines, there appears to be consensus that severe hypertension and non-severe hypertension with evidence of end-organ damage need to be controlled; yet the ideal target ranges below 160/110 mmHg remain a source of debate. This review outlines the definition, pathophysiology, goals of therapy, and treatment agents used in hypertensive disorders of pregnancy.

scholarly journals Prolonged use of methyldopa in severe hypertension in pregnancy.

BMJ ◽  
1966 ◽  
Vol 1 (5482) ◽  
pp. 274-276 ◽  
Author(s):  
P. Kincaid-Smith ◽  
M. Bullen ◽  
J. Mills
Keyword(s):  
Severe Hypertension ◽  
Hypertension In Pregnancy ◽  
In Pregnancy
Sign in / Sign up

Export Citation Format

Share Document